Dr Kenneth W Parks, DDS | |
636 West Mcneese St, Lake Charles, LA 70605 | |
(337) 477-6124 | |
(337) 477-6885 |
Full Name | Dr Kenneth W Parks |
---|---|
Gender | Male |
Speciality | Dentist - Endodontics |
Location | 636 West Mcneese St, Lake Charles, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043326390 | NPI | - | NPPES |
1838730 | Medicaid | LA | |
G1204 | Other | BLUE CROSS OF LA | |
807933 | Other | UNITED CONCORDIA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223E0200X | Dentist - Endodontics | 3873 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kenneth W Parks, DDS 636 West Mcneese St, Lake Charles, LA 70605 Ph: (337) 477-6124 | Dr Kenneth W Parks, DDS 636 West Mcneese St, Lake Charles, LA 70605 Ph: (337) 477-6124 |
News Archive
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Progress in reducing colorectal cancer (CRC) mortality rates varies significantly across states, with rates in the Northeast showing the most progress and those in the South showing the least progress, according to a new study.
Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 3 days ago
Dr. John Ferrell Moffett Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1509 W Mcneese St, Lake Charles, LA 70605 Phone: 337-479-0300 Fax: 337-477-5777 | |
Dr. Ronald Michael Short, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1702 Oak Park Blvd, Lake Charles, LA 70601 Phone: 337-310-1800 Fax: 337-310-1143 | |
Dr. Philip D Moses, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 631 W College St, Lake Charles, LA 70605 Phone: 337-474-9057 Fax: 337-474-9444 | |
Dr. Peter J. Dorsey, D. D. S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3447 5th Ave, Lake Charles, LA 70607 Phone: 337-478-2014 Fax: 337-480-1846 | |
Dr. Blake Everett Price, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3451 Nelson Rd, Lake Charles, LA 70605 Phone: 337-479-2273 Fax: 337-478-2212 | |
Leonard C Breda Iii, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 903 Mill St, Lake Charles, LA 70601 Phone: 337-433-5545 Fax: 337-433-5527 |